登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605299 证券简称：舒华体育 公告编号：2025-061 第五届董事会第三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 舒华体育股份有限公司（以下简称"公司"）第五届董事会第三次会议于2025年12月16日以现场结合通讯 表决方式在公司会议室召开，全体董事一致同意豁免本次会议的提前通知要求。本次会议由董事长张维 建先生主持，本次会议应出席董事9人，实际出席董事9人。公司高级管理人员列席了会议。本次会议的 召集、召开符合《中华人民共和国公司法》《公司章程》的有关规定，决议内容合法有效。 二、董事会会议审议情况 （一）审议通过《关于豁免公司第五届董事会第三次会议通知期限的议案》 全体董事一致同意豁免本次临时董事会提前通知义务，于2025年12月16日召开公司第五届董事会第三次 会议。 表决结果：9票赞成，0票反对，0票弃权。 舒华体育股份有限公司 （二）审议通过《关于拟对外投资建设项目的议案》 具体内容详见于2025年12月1 ...

Group 1 - The company Dong-E E-Jiao has been awarded the title of "National Advanced Unit for Mass Sports" for the period of 2021-2024 by the General Administration of Sport of China, recognizing its efforts in promoting health services and mass fitness activities [1][3] - Dong-E E-Jiao has actively implemented the "Strong Sports Nation" strategy and has committed to safeguarding public health by organizing various employee sports activities and supporting high-quality development in sports [3] - Starting in 2024, Dong-E E-Jiao will establish a strategic partnership with the Shandong Provincial Sports Bureau, sponsoring the Shandong team in the National Super League and the Shandong Marathon, while also becoming a strategic partner for the Shandong delegation at the 15th National Games [3] Group 2 - The company's core products, including "Dong-E E-Jiao," "Compound E-Jiao Syrup," and "Peach Blossom Princess E-Jiao Cake," have been designated as the official products for the Shandong sports delegation at the 15th National Games [3] - Dong-E E-Jiao is planning to build employee health service centers and is focused on enhancing the physical fitness and health levels of its employees through various sports activities [3] - The company aims to integrate traditional Chinese medicine with sports health initiatives, driving innovation in the TCM sector and contributing to the national health development strategy [3]

Core Insights - The "Five Advances" health care service plan has been implemented at the headquarters of China Petroleum & Chemical Corporation (Sinopec), providing various health services to employees during the first snowfall of winter in Beijing [1][3]. Group 1: Health Services Offered - The "Five Advances" plan includes health lifestyle experiences, health screenings, and health consultations tailored to the health needs of Sinopec employees [1]. - A special "Famous Doctor Health Consultation" session was organized, featuring specialists from Peking Union Medical College Hospital who provided one-on-one health advice to employees [2]. Group 2: Future Initiatives - The "Five Advances" plan will continue to collaborate with central authorities, local governments, large enterprises, and authoritative social organizations to promote health services [2]. - The initiative aims to enhance public health awareness and improve the overall health and happiness of the community by engaging in various educational activities across different sectors [2].

Core Insights - The article highlights that Binzhou Medical College Affiliated Hospital has been recognized as an "Excellent Unit" in the "Whole Hospital Lung Function Construction Center" evaluation, standing out among over 300 participating hospitals nationwide [1][2] - The initiative aims to enhance the early diagnosis and treatment capabilities for chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), in alignment with the "Healthy China" strategy [1] Group 1: Recognition and Achievements - Binzhou Medical College Affiliated Hospital was awarded as one of the 28 excellent units in the national evaluation, indicating its advanced capabilities in lung function management [1] - The hospital's lung function department has established a comprehensive quality control system and chronic disease management processes since its inception in 1995 [2] Group 2: Clinical Applications and Innovations - The lung function department applies lung function tests across various clinical scenarios, including COPD, asthma, and preoperative assessments, significantly improving diagnostic accuracy and patient outcomes [2] - The department conducts a wide range of tests, such as bronchial dilation tests and FeNO testing, achieving leading standards in both test variety and quality control in China [2] Group 3: Future Directions - The recognition as an excellent unit signifies the hospital's commitment to further enhancing its internal construction and optimizing the management model for lung function checks [2] - The respiratory and critical care medicine department plans to leverage its status to foster regional healthcare improvements through technical support, talent development, and academic exchanges [2]

Core Insights - The article highlights the advancements and stability of China's healthcare insurance system during the "14th Five-Year Plan" period, emphasizing the establishment of a more equitable and efficient national healthcare network. Group 1: Healthcare Coverage - The national basic healthcare insurance coverage rate remains stable at around 95% during the "14th Five-Year Plan" period, with the number of insured individuals reaching 1.327 billion by 2024 [3] - The payment ratio for inpatient expenses is maintained at approximately 80% for employees and 70% for residents [3] Group 2: Financial Stability - By the end of 2024, the cumulative balance of the healthcare insurance fund is projected to reach 3.86 trillion yuan [4] - The basic healthcare insurance fund expenditure for 2024 is estimated at 2.98 trillion yuan, with a year-on-year decrease of about 5% in patient out-of-pocket expenses [16] Group 3: Long-term Care and Support - Over 8,800 long-term care service institutions have been established, with 300,000 care service personnel available [7][9] - The long-term care insurance system has expanded to cover 190 million people, benefiting over 2 million disabled individuals and reducing their care service costs by more than 50 billion yuan [9] Group 4: Drug Accessibility and Innovation - A total of 402 new drugs have been added to the healthcare insurance directory since the beginning of the "14th Five-Year Plan," with spending on innovative drugs in 2024 being 3.9 times that of 2020 [14] - More than 100 drugs are currently under application for inclusion in the innovative drug directory [14] Group 5: Service Improvement and Accessibility - The initiative to create a "15-minute healthcare service circle" has led to over 1.236 billion people using healthcare codes by June 2025 [24] - The online handling rate of healthcare administrative services has increased from 55% in 2020 to 92% in 2024 [24] - Cross-province direct settlement services for medical treatment have exceeded 500 million instances during the "14th Five-Year Plan" period [24] Group 6: Support for Vulnerable Populations - Since 2018, healthcare assistance has supported 350 million instances for low-income individuals, maintaining a 99% insurance coverage rate for rural low-income and poverty-stricken populations [25] - The reimbursement ratio for rural low-income individuals under the three-tiered support system exceeds 90% [25]

Core Insights - Jinan International Medical Center is transforming into a national-level health industry hub, leveraging policy benefits, financial support, and high-end medical resources to establish a "high-end, specialized, and international" development pattern by 2025 [1][3][10] Medical Services - The Shandong Proton Center within the medical center has treated nearly 2,000 patients, ranking first in the 2024-2025 China Proton and Heavy Ion Center rankings, showcasing advancements in precision radiation therapy [2] Technological Innovation - The medical center is actively participating in major medical technology exhibitions, introducing innovative technologies such as Hi-tACS for treating neuropsychiatric disorders and AI-assisted diagnostic systems, enhancing the development of precision medicine [4][5] Health Industry Development - The Jinan government is supporting the establishment of a national medical center and accelerating the development of medical parks, ensuring efficient招商 (investment attraction) processes through comprehensive management strategies [6][7] International Cooperation - The medical center is expanding its international collaboration by signing agreements with institutions in South Korea, focusing on various medical fields, and hosting annual Sino-Korean health industry cooperation conferences [8] Resource Support - The Shandong government has introduced tailored policies to support the medical center, including financial backing through various funds, facilitating the approval of medical devices, and enhancing project execution efficiency [9][10]

Core Viewpoint - Kunlun Health Insurance has launched its first "Health Home" in Shanghai, aiming to integrate health services into community governance and contribute to the "Healthy Shanghai" initiative [1][3]. Group 1: Community Integration - The "Health Home" in Yongding Community serves as a model for integrating health services into urban community governance [3]. - Kunlun Health Insurance has donated emergency first aid kits to 36 communities in Changshou Road Street, supporting the establishment of a "Community Micro Fund" for health activities [4]. Group 2: Service Offerings - The "Health Home" aims to provide a comprehensive service platform that includes health monitoring, disease prevention, knowledge dissemination, and insurance planning [6]. - The site will offer basic health checks, dynamic monitoring, and risk alerts, focusing on the core health needs of residents [10]. Group 3: Resident Engagement - Residents have positively received the "Health Home," appreciating the accessibility of health monitoring and professional consultations [8]. - The initiative allows residents to engage in health checks and learn about health management conveniently within their community [8].

据了解，国家重点研发计划是当前中国最高级别的研发项目，由原973计划、863计划、国家科技支撑计 划、国际科技合作与交流专项、发改委和工信部共同管理的产业技术研究与开发基金，以及农业部、卫 健委等部门管理的公益性行业科研专项等整合而成。该计划聚焦事关国计民生的重大社会公益性研究， 以及战略性、基础性、前瞻性重大科学问题和关键共性技术研发，为国民经济和社会发展提供持续性支 撑和引领。 近日，科技部发布2025年度国家重点研发计划"诊疗装备与生物医用材料"重点专项项目的立项通知。南 京医科大学第三附属医院(常州二院)倪昕晔教授牵头申报的"放射治疗用EPID影像引导逐控制点在体剂 量实时验证关键技术研究及样机研制"项目获批立项。 这是江苏放疗专业、常州卫生系统职工首个作为项目负责人获批的国家重点研发计划项目。 该项目直面我国放射治疗领域在体剂量验证的"卡脖子"难题，整合高校、医院及相关领域头部企业的优 势资源，构建"高校-医院-企业"三位一体的协同创新机制，实现从基础研究、技术攻关到产业转化的全 链条覆盖。 研究成果将为实时自适应放疗等前沿领域的临床转化与产业升级提供关键支撑，对实施"健康中国"的战 略实施、保障放 ...

Core Insights - The article highlights the significant improvements in grassroots healthcare services in China, emphasizing the convenience and efficiency experienced by patients [1] - The introduction of the 2025 dual directory for medical insurance and commercial insurance, effective from January 1, 2024, is a key development, featuring a new list of innovative drugs [1] - The inclusion of critical innovative drugs, such as CAR-T therapy for leukemia, in the commercial insurance directory is expected to alleviate the financial burden on patients [1] Group 1 - The grassroots healthcare system has been upgraded, allowing for quick and efficient medical services, with common medications available through insurance [1] - The newly established commercial insurance innovative drug directory includes 19 essential drugs for major diseases, selected by a professional committee [1] - CAR-T therapy, a vital treatment for leukemia, is now included in the commercial insurance directory, significantly reducing patient costs [1] Group 2 - The focus of health services is shifting towards preventive care, aligning with the "14th Five-Year Plan" to promote health awareness among the public [2] - Over 90% of residents can access healthcare services within 15 minutes, enhancing the capability of community hospitals to handle common ailments [2] - Improving public health literacy is crucial for transitioning from a reactive to a proactive health management approach [2]

Group 1 - The "Healthy China 2030" initiative is driving the development of the health industry as a key engine for high-quality economic growth, with a focus on improving life expectancy and health levels [1] - The integration of agriculture and biotechnology is seen as a new approach to advance the health industry, supported by the recent "14th Five-Year Plan" which emphasizes the implementation of health priority development strategies [1] - A recent symposium aimed at promoting collaborative efforts among government, industry, finance, academia, and media to explore new pathways for high-quality development in the health industry [1] Group 2 - San Zhu Grain Group has developed a complete industrial system for oat production over nearly 30 years, holding over 80 national technology patents, including an award-winning project for drought-resistant oat varieties [3][4] - Oats are recognized as a functional food with significant health benefits, particularly for chronic disease patients, and are positioned to change the traditional staple food landscape in northern China [6] - Research collaboration between San Zhu Grain and Peking University has demonstrated that daily intake of 50-100g of naked oats has significant nutritional therapeutic effects for type 2 diabetes patients, providing scientific evidence for functional food development [6] - The development of oat peptides represents a key breakthrough for San Zhu Grain's transition to biotechnology, enhancing the absorption of oat protein and retaining its physiological activity [6]